Odyssey Evaluation in Post LASIK Patients
Part of paid clinical trials in Venice, Florida.
- Sponsor
- Center For Sight
- Study ID
- NCT07260695
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Cataract
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Odyssey intraocular lens — DEVICEThe Odyssey intraocular lens is intended to be implanted at the time of cataract surgery to replace the natural lens.
Study Details
This prospective study evaluates the visual and refractive outcomes of the TECNIS Odyssey intraocular lens (IOL) implanted in patients with a history of myopic LASIK. Given the unique optical challenges of post-LASIK eyes, including altered corneal curvature and higher-order aberrations, the study aims to assess the IOL's performance in terms of distance, intermediate, and near vision, and patient satisfaction. Its design features may offer favorable outcomes in these patients.
Key Dates
- Start date
- Aug 18, 2025
- Status verified
- Dec 2025
- Primary completion
- Aug 18, 2026
- Completion
- Aug 18, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: Odyssey IOL
Primary Outcome Measure
Binocular defocus curve [ Time Frame: 3 months postoperatively ]
Central Contacts
- Helga P Sandoval8438813937
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center For Sight | Venice | Florida | 34285 |
Find similar trials in Venice, FL
By research site
Related Studies
- IC-8 Apthera IOL New Enrollment Post Approval StudyRecruiting · Bausch & Lomb Incorporated · Dothan, Alabama
- A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)PHASE3 · Recruiting · Melt Pharmaceuticals · Chico, California
- Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+Not Yet Recruiting · The Eye Associates · Bradenton, Florida
- Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOCPHASE1/PHASE2 · Recruiting · Inder Paul Singh, M.D. · Venice, Florida